科研之友
微信
新浪微博
Facebook
分享链接
摘要
Little progress has been made in the pharmacological management of patients with hepatic encephalopathy, partly because it is difficult to perform clinical trials in this group of patients. A new clinical trial now suggests that polyethylene glycol is more effective than the current standard first-line therapy in these patients. maxkabakov/iStock/Thinkstock
- 出版日期2015-1
